Pre-sensitization of Malignant B Cells Through Venetoclax Significantly Improves the Cytotoxic Efficacy of CD19.CAR-T Cells

• Mingya Yang,
• Mingya Yang,
• Lei Wang,
• Ming Ni,
• Ming Ni,
• Brigitte Neuber,
• Sanmei Wang,
• Sanmei Wang,
• Wenjie Gong,
• Wenjie Gong,
• Tim Sauer,
• Leopold Sellner,
• Leopold Sellner,
• Maria-Luisa Schubert,
• Angela Hückelhoven-Krauss,
• Jian Hong,
• Lixin Zhu,
• Christian Kleist,
• Volker Eckstein,
• Carsten Müller-Tidow,
• Carsten Müller-Tidow,
• Peter Dreger,
• Peter Dreger,
• Michael Schmitt,
• Michael Schmitt,
• Anita Schmitt

Affiliations

Mingya Yang

Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany

Mingya Yang

Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Anhui, China

Lei Wang

Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany

Ming Ni

Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany

Ming Ni

Department of Hematology, The Affiliated Hospital of Guizhou Medical University, Guizhou, China

Brigitte Neuber

Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany

Sanmei Wang

Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany

Sanmei Wang

Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China

Wenjie Gong

Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany

Wenjie Gong

Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China

Tim Sauer

Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany

Leopold Sellner

Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany

Leopold Sellner

Oncology Business Unit-Medical Affairs, Takeda Pharma Vertrieb GmbH & Co. KG, Berlin, Germany

Maria-Luisa Schubert

Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany

Angela Hückelhoven-Krauss

Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany

Jian Hong

Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Anhui, China

Lixin Zhu

Department of General Surgery and Central Laboratory, The First Affiliated Hospital of Anhui Medical University, Anhui, China

Christian Kleist

Department of Nuclear Medicine, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany

Volker Eckstein

Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany

Carsten Müller-Tidow

Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany

Carsten Müller-Tidow

National Center for Tumor Diseases (NCT), German Cancer Consortium (DKTK), Heidelberg, Germany

Peter Dreger

Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany

Peter Dreger

National Center for Tumor Diseases (NCT), German Cancer Consortium (DKTK), Heidelberg, Germany

Michael Schmitt

Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany

Michael Schmitt

National Center for Tumor Diseases (NCT), German Cancer Consortium (DKTK), Heidelberg, Germany

Anita Schmitt

Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany